About Syntarga
Syntarga B.V. is a biopharmaceutical company creating innovative chemistries to link anticancer activity to specificity. The Company develops highly potent cell-killing drugs, releasable linker technologies and linker-drug combinations for conjugation to tumor-specific antibodies and mAb derivatives. Syntarga focuses its activities on the development of complete antibody payload chemistries, which, in combination with a third party antibody, yield successful Antibody-Drug Conjugate (ADC) products.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of Syntarga
News about Syntarga
Here you will find Syntarga BV
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
